Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends – 2012...市場調査レポートについてご紹介

【英文タイトル】Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Pharmaceutical & Healthcare, Global, Deals Summary 9
2.1 Pharmaceutical & Healthcare, Global, Deals Analysis, 2012 9
2.1.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, 2012 by Quarter 11
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, 2012 13
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, 2012 14
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, 2012 15
2.5 Pharmaceuticals & Healthcare, Top Deals, Global, Summaries, 2012 16
2.5.1 Abbott Completes Private Placement of Notes for $14.7 Billion 16
2.5.2 Nestle Completes Acquisition of Pfizer Nutrition from Pfizer for $11.85 Billion 16
2.5.3 Roche Revises Offer Price to Acquire Illumina for Up To $8.2 Billion 16
2.5.4 Aetna Receives Shareholders Approval to Acquire Coventry Health Care for $7.3 Billion 17
2.5.5 Walgreen Acquires 45% Stake in Alliance Boots from KKR And AXA Private Equity for $6.7 Billion 17
2.5.6 Watson Pharma Completes Acquisition of Actavis Group for $5.92 Billion 18
2.5.7 Bristol-Myers Squibb Completes Acquisition of Amylin Pharma for $5.3 Billion 19
2.5.8 GlaxoSmithKline Completes Public Offering of Notes for $5 Billion 19
2.5.9 UnitedHealth Completes Acquisition of 60% Stake in Amil Participacoes 19
2.5.10 WellPoint Completes Acquisition of Amerigroup for $4.9 Billion 20
3 Pharmaceuticals & Healthcare, Global, Top Deal Makers, 2012 21
4 Pharmaceuticals & Healthcare, Global, Deal Summary, by Type 22
4.1 Pharmaceuticals & Healthcare, Global, M&A, 2012 22
4.1.1 Pharmaceuticals & Healthcare, Global, M&A, 2012 by Quarter 23
4.1.2 Top M&A Deals in 2012 24
4.1.3 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, 2012 25
4.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2012 26
4.2.1 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2012 by Quarter 27
4.2.2 Pharmaceuticals & Healthcare, Global, IPO Deals, 2012 28
4.2.3 Pharmaceuticals & Healthcare, Global, Secondary Offerings Deals, 2012 30
4.2.4 Pharmaceuticals & Healthcare, Global, PIPE Deals, 2012 32
4.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, 2012 34
4.3 Pharmaceuticals & Healthcare, Global, Debt Offering Deals, 2012 35
4.3.1 Pharmaceuticals & Healthcare, Global Debt Offerings, 2012 by Quarter 36
4.3.2 Pharmaceuticals & Healthcare, Global, Public Debt Offerings, 2012 37
4.3.3 Pharmaceuticals & Healthcare, Global, Private Debt Placements, 2012 38
4.3.4 Pharmaceuticals & Healthcare, Global, Debt Offering Deals, by Therapy Area, 2012 39
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, 2012 40
4.4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, 2012 by Quarter 41
4.4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, 2012 43
4.4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Value (US$ m), 2012 44
4.4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2012 45
4.4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, 2012 46
4.4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), 2012 47
4.4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2012 48
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2012 51
4.5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2012 by Quarter 52
4.5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, 2012 53
4.5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Upfront & Milestone Payments and Deal Value (US$ m), 2012 54
4.5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2012 55
4.5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), 2012 56
4.5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), 2012 57
4.5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2012 58
4.6 Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2012 61
4.6.1 Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2012 by Quarter 62
4.6.2 Top Private Equity Deals in 2012 63
4.6.3 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, 2012 64
4.7 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, 2012 65
4.7.1 Pharmaceuticals & Healthcare, Global, Venture Financing Deals, 2012 by Quarter 66
4.7.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, 2012 67
4.7.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, 2012 68
4.7.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, 2012 69
4.7.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year 70
4.7.6 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, 2012 71
4.7.7 Top Venture Financing Deals in 2012 72
5 Pharmaceuticals & Healthcare, Global, Deal Summary, By Market 73
5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, 2012 73
5.1.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, 2012 by Quarter 75
5.1.2 Oncology – Deals of the Year 76
5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2012 78
5.2.1 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2012 by Quarter 79
5.2.2 Central Nervous System – Deals of the Year 80
5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2012 82
5.3.1 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2012 by Quarter 83
5.3.2 Infectious Disease – Deals of the Year 84
5.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, 2012 86
5.4.1 Pharmaceuticals & Healthcare, Global, Immunology Deals, 2012 by Quarter 87
5.4.2 Immunology – Deals of the Year 88
5.5 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2012 90
5.5.1 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2012 by Quarter 91
5.5.2 Cardiovascular – Deals of the Year 92
5.6 Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2012 93
5.6.1 Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2012 by Quarter 94
5.6.2 Metabolic Disorders – Deals of the Year 95
5.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2012 97
5.7.1 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2012 by Quarter 98
5.7.2 Gastrointestinal – Deals of the Year 99
6 Pharmaceuticals & Healthcare, Deal Summary, By Geography 101
6.1 Pharmaceuticals & Healthcare, North America Region, Deals, 2012 101
6.1.1 Pharmaceuticals & Healthcare, North America Region, Deals, 2012 by Quarter 102
6.1.2 North America – Deals of the Year 103
6.2 Pharmaceuticals & Healthcare, European Region Deals, 2012 106
6.2.1 Pharmaceuticals & Healthcare, Europe, Deals, 2012 by Quarter 107
6.2.2 Europe – Deals of the Year 108
6.3 Pharmaceuticals & Healthcare, Asia-Pacific Region, Deals, 2012 110
6.3.1 Pharmaceuticals & Healthcare, Asia-Pacific Region Deals, 2012 by Quarter 111
6.3.2 Asia-Pacific – Deals of the Year 112
6.4 Pharmaceuticals & Healthcare, Rest of the World (ROW) Deals, 2012 114
6.4.1 Pharmaceuticals & Healthcare, Rest of the World Deals, 2012 by Quarter 115
6.4.2 Rest of the World – Deals of the Year 116
7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 117
7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, 2012 117
7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, 2012 118
8 Further Information 119
8.1 Methodology 119
8.2 About GlobalData 120
8.3 Contact Us 120
8.4 Disclosure information 120
8.5 Disclaimer 120


【レポート販売概要】

■ タイトル:Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends – 2012
■ 英文:Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012
■ 発行日:2013年3月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160699
■ 調査対象地域:グローバル
  • 2014年戦略提言:世界の血液凝固検査市場
    Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.SummaryThis comprehensive seven-country report contains 650 pages, 150 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global coagulation testing market during the next five years.  The report explores bus …
  • クロマトグラフィー樹脂の世界市場:天然高分子、合成高分子、無機メディア
    The chromatography resin market size is estimated to grow USD 2.3 Billion by 2020, at a CAGR of 7.3% between 2015 and 2020. North America dominates the chromatography resins market in terms of volume. The region accounts for approximately 40.1% share in the chromatography resins market in terms of volume in 2014. The large market size is mainly due the huge demand from key end-user industries such …
  • HVAC(空調)装置購買の世界市場:購買動向、バリューチェーン、市場シェア、価格・コスト分析
    About HVAC Systems Heating, ventilation, and air conditioning (HVAC) refers to systems that perform processes designed to regulate room temperature, humidity, and air flow in buildings, as per their acceptable range. HVAC systems are an important part of: • Architectural design and space allocations • Building construction budget TechNavio's analysts forecast the Global Procurement of HVAC Systems …
  • ダイヤモンド採掘の世界市場:宝石細工、産業用途
    Technavios market research analyst predicts the diamond mining industry to grow at a CAGR of around 5% during the forecast period. The increased demand from emerging markets such as China and India for diamond jewelry is driving the growth of this industry. The average amount spent on diamond jewelry by married women is around USD 1500 followed by single women who spent an average of USD 1100 duri …
  • 不織布-産業用メンブレンの世界市場予測(~2021年)
    MarketsandMarkets projects that the market for non-woven fabrics industrial membranes will grow from USD 608.9 Million in 2016 to USD 959.5 Million by 2021, at a CAGR of 9.52%. This market is growing because of the increase in demand for fresh water from industries such as medicals, infrastructures, and construction activities. The growth in demand for desalination is also expected to positively i …
  • 世界のインメモリーコンピューティング市場:Global In-memory Computing Market 2014-2018
    TechNavio's analysts forecast the Global In-Memory Computing market to grow at a CAGR of 43.86 percent over the period 2014-2018. One of the key factors contributing to this market growth is the rapid data explosion in networks. The Global In-Memory Computing market has also been witnessing the rise in demand from SMEs. However, the data security issues and lack of confidence could pose a challeng …
  • がん分子標的治療の世界市場及びインサイト
    Cancer targeted therapeutics global market could be broadly divided into small and large molecules segments. Small molecules generate significant shares due to their sheer numbers as compared to large molecules cancer targeted therapeutics. Moreover, they have mature market and they could be considered as pioneer due to which they have more market penetration across the globe. Their prices have go …
  • 再生医療の世界市場予測(~2021年):細胞治療、組織工学、免疫治療、遺伝子治療
    “Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), By Product (Cell-Based, Acellular), By Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology)-Forecast To 2021” The global Regenerative medicine market is expected to reach USD 38.70 billion by 2021 from USD 13.41 billion in 2016 at a CAGR of 23.6% from 2016 t …
  • シンガポールの生鮮キノコ市場
    About Mushrooms Mushrooms are porous, fleshy, and spongy and are most often considered as vegetables. They have both individual consumers and foodservice providers as primary consumers. Because of their medicinal and nutritional values, consumers in Singapore are willing to pay more for healthy, fresh, and hygienically-packed fresh mushrooms. However, Singapore is a net importer of fresh mushrooms …
  • 消泡剤の世界市場
    ABSTRACTAbout Anti-Foaming Agent Anti-foaming agents are chemical additives that minimize and stop the formation of foam. They are mainly used in industrial process liquids to reduce the formation of foam. Foam formation leads to flaws on surface coatings and prevents efficient filling of containers. Foam formation is the major problem faced while developing coatings and printing inks by formulati …
  • 産業用汚泥処理化学薬品の世界市場:凝固剤、凝集剤、腐食抑制剤、スケール防止剤、殺生物剤、消泡剤
    About Industrial Sludge Treatment Sludge is a mixture of liquids and solids generated during the treatment of wastewater. It contains water along with different organic materials, chemicals, pathogens, and diverse microorganisms. The sludge produced by different industries comprise pollutants (heavy metals, pathogens, and organic pollutants) and compounds of agricultural value (organic matter, pho …
  • スマートロボットの世界市場:個人向けサービスロボット、スマートモバイルロボット、協力ロボット
    About the Smart Robots Market Robotic vacuum cleaners emerged in the market in the late 1990s and early 2000s. However, the adoption of robotic vacuum cleaners remained low during the both the periods due to product inefficiencies like limited suction power and random movement pattern to clean floors. However, technological innovations, availability of new advanced products such as infrared sensor …
  • 世界における小型自動車用電子制御ブレーキング市場(2008-2028)
    This latest just-auto report edition offers a global review of the OE electronic braking sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE electronic braking market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategi …
  • 世界のジオマーケティングソフトウェア市場:展開別、ロケーション別、地域別
    Global Geomarketing Software Market: About this market Technavio’s geomarketing software market analysis considers sales from both outdoor and indoor locations. Our study also finds the sales of geomarketing software in APAC, Europe MEA, North America, and South America. In 2019, the outdoor segment had a significant market share, and this trend is expected to continue over the forecast period. Fa …
  • 世界の食品用潤滑剤市場2015
    The Global Food Grade Lubricants Industry Report 2015 is a professional and in-depth study on the current state of the Food Grade Lubricants industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Food Grade Lubricants market analysis is provided for the international markets including development trends, …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。